No Data
No Data
Oppenheimer Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $18
Cantor Fitzgerald Initiates Voyager Therapeutics(VYGR.US) With Buy Rating
Cantor Fitzgerald Initiates Voyager Therapeutics at Overweight
Solid Biosciences Stock Jumps 11% Post-market on FDA Update
Voyager Therapeutics, Inc. (VYGR): Is This Gene Therapy Stock a Good Buy Right Now?
Institutional Investors Own a Significant Stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
LEEER利爾 OP : Good news, it’s time to surge